TMCI Treace Medical Concepts Inc

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of...

Latest Ratings for TMCI DateFirmActionFromTo Mar 2022Morgan StanleyMaintainsOverweight Mar 2022StifelMaintainsBuy Jan 2022Morgan StanleyUpgradesEqual-WeightOverweight View More Analyst Ratings...

Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to expanded surgeon base and product mix shift. FY24 sales guidance adjusted...

For the last three days, A.I.dvisor has detected that TMCI's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

For the last three days, A.I.dvisor has detected that TMCI's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI Get Free Report) traded up 7.6% during trading on Wednesday . The company traded as high as $12.35 and last traded at $12.35. 276,067...